Welcome to START
START is dedicated to the conduct of Phase I
Clinical Trials of novel anticancer agents.
Mission Statement
The mission of START is to accelerate the development of new anticancer drugs with the purpose of improving quality of life and survival for patients with cancer. START consists of a team of highly trained physicians and staff with extensive experience in Phase I clinical trials research.
We’re Expanding!
We are expanding globally with the launch of START Madrid. The Madrid unit will be led by Emiliano Calvo, M.D., Ph.D., Director of Clinical Research. He will be joined by Ignacio Durán, M.D., Ph.D., Associate Director of Clinical Research, and Manuel Hidalgo, M.D., Ph.D., Director of the Centro Integral Oncológico Clara Campal. Drs. Calvo and Hidalgo trained with Dr. Tolcher in San Antonio, TX.
This International program is the first step in our goal to keep the development of anticancer agents operating 24 hours a day. Because of the work of scientists like those at START and START Madrid, real progress is being made against cancer. Through the hard work of these physicians and the continuing advances in technology we are able to improve the tools to understand, detect, and diagnose cancer. Today, people with cancer are living longer than ever before with a better quality of life.
Contact
Gina L. Mangold, MBA
Chief Operating Officer
Phone: (210) 593-5250
Fax: (210) 615-1121
E-mail: gina.mangold@start.stoh.com
 |
|
4319 Medical Drive, Suite 205
San Antonio, TX 78229
Directions
|
The future home of START will be located at the
corner
of Medical Drive and Ewing Halsell Drive
coming December 2008.
|
